Opus Genetics, Inc.
NASDAQ:IRDBiotechnology
-$0.01 today
- Market cap
- $326.13M
- Beta
- 0.55
- P/E (TTM)
- -33.0
- EPS (TTM)
- -$0.12
Volume 0.75M
Average 0.81M
IRD Property, Plant & Equipment (Net)
Physical long-term assets such as land, buildings, and machinery, net of accumulated depreciation.
Opus Genetics, Inc.NASDAQ: IRD
Property, Plant & Equipment (Net) · Q1 FY2026 · quarter ended Mar 2026
Property, plant & equipment (net) falls 22.2% from a year ago
Property, plant & equipment (net) stood at $186K at the end of Q1 FY2026, down 22.2% from a year earlier and down 6.5% from the prior quarter. Over 3 fiscal years it compounded at +221.3% a year.
Context
- Property, plant & equipment (net) amounted to 0.3% of total assets at the end of Q1 FY2026, down 0.2 pp from a year earlier.
- Property, plant & equipment (net) increased in 1 of the last 3 fiscal years.
What to watch
Whether property, plant & equipment (net) keeps falling in the next quarterly balance sheet after a -22.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Property, Plant & Equipment (Net) history
USD · from the balance sheet
- Latest · FY2025
- 199K USD
- Year-over-year change
- -21.0%
- 4-year CAGR
- +111.2%
| Period | Period end | Property, Plant & Equipment (Net) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 199K | -21.0% |
| FY2024 | 2024-12-31 | 252K | — |
| FY2023 | 2023-12-31 | 0 | -100.0% |
| FY2022 | 2022-12-31 | 6K | -40.0% |
| FY2021 | 2021-12-31 | 10K | — |
Property, Plant & Equipment (Net) vs competitors
How IRD compares with its peers on the latest reported figures
- IRD's Mar 2026 property, plant & equipment (net) of $186K is the 9th highest of the 10 companies compared; the peer median is $8.33M.
- Its year-over-year change of -22.2% is the 4th highest of 10, against a peer median of -35.9%.
- Property, plant & equipment (net) amounts to 0.3% of total assets for IRD, versus a peer median of 9.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $77.08M | -13.8% | -15.7% | 65.5% | |
| Mar 2026 | $33.38M | -15.0% | -8.8% | 12.3% | |
| Mar 2026 | $22.62M | -35.9% | -22.8% | 9.4% | |
| Mar 2026 | $22.41M | -84.4% | -47.2% | 12.0% | |
| Mar 2026 | $8.33M | -24.9% | -20.4% | 16.7% | |
| Mar 2026 | $675.65K | +115.7% | +17.9% | 2.3% | |
| Mar 2026 | $326K | -48.6% | -27.5% | 0.9% | |
| Mar 2026 | $197K | -47.2% | -3.5% | 0.1% | |
IRDOpus Genetics, Inc. | Mar 2026 | $186K | -22.2% | +221.3% | 0.3% |
| Mar 2026 | $172K | -81.4% | -88.0% | 0.1% | |
| Peer median (excluding IRD) | $8.33M | -35.9% | -20.4% | 9.4% | |
Competitors are the stored peer set for IRD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Opus Genetics, Inc.
NASDAQ:IRD
Intrinsic Alpha fair value
Locked
Current Price
$3.92
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.